11 results
AACE/ACE 2018 Glycemic Control Algorithm

#AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
AACE/ACE 2018 Glycemic ... #AACE #2018 # ... Glycemic #Diabetes #DM2 ... #Control #Medication ... #Algorithm #Endocrinology
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
of Antidiabetic Medications ... - AACE 2018 ... #Antidiabetic #Medications ... DecisionAid #Orals #DM2 ... #Diabetes #Endocrinology
Algorithm for Management of the Overweight/Obese Patient - AACE 2018 Guidelines

#Obese #Obesity #AACE #2018 #Guidelines #Algorithm
Algorithm for Management ... Obese Patient - AACE ... 2018 Guidelines ... #2018 #Guidelines ... #Endocrinology
Diabetes Medication Prescribing Algorithm

- Dr. Eric Strong @DrEricStrong - Strong Medicine https://www.youtube.com/c/EricsMedicalLectures/featured

#Diabetes #Medications #Prescribing #Algorithm #management
Diabetes Medication ... Prescribing Algorithm ... #Prescribing #Algorithm ... #management #endocrinology ... #dm2
AACE/ACE 2016 Postmenopausal Osteoporosis Treatment Algorithm

Evaluate for causes of secondary osteoporosis

Correct calcium/vitamin D deficiency and address
AACE/ACE 2016 Postmenopausal ... benefits and risks of medications ... #Osteoporosis #AACE ... #2016 #Postmenopausal ... #Treatment #Algorithm
Diabetes Type 2 Medication Management and Titration Algorithm
- First line therapy is metformin and comprehensive lifestyle
Diabetes Type 2 Medication ... and Titration Algorithm ... CKD #Diabetes #DM2 ... #Type2 #Medication ... #endocrinology
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... #diabetes #medications ... #table #comparison ... #management #endocrinology ... #dm2
Table of Weight-Loss Medications approved by the FDA for the long-term treatment of Obesity

Mechanism of Action,
of Weight-Loss Medications ... mg #Obesity #Medications ... #WeightLoss #AACE ... #2016 #Pharmacology ... #Table #Comparison
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Diabetes #Mellitus #DM2 ... #Inpatient #Medications ... #pharmacology #comparison ... #table #endocrinology
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
anti-diabetic medications ... being approved in 2013 ... #Pharmacology #Medications ... #DM2 #Diabetes ... #Endocrinology